- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Caplin Point Laboratories Limited — Updates, 23-10-2025: Press Release
23-10-2025 | 02:51 pm
23-10-2025 | 02:51 pm
Caplin Steriles secured USFDA approval for Nicardipine Hydrochloride Injection, targeting a $6.8 Cr US market. Additionally, Caplin acquired four ANDAs with a $12.1 Cr combined US market. These new products are slated for 2026 launch.
No comments yet. Be the first to comment!